Reports a study in the February issue of The Pediatric Infectious Disease Journal.

By age group two, kids getting the 5-in-1 vaccine had fewer days without all suggested vaccinations: about 30 days on average, in comparison to 70 days in the DTaP group. Thus children getting the 5-in-1 vaccine spent not even half as enough time at risk of serious infections. The distinctions remained significant after adjustment for various other factors affecting vaccination rates, such as competition/ethnicity. Related StoriesKey part of MRSA vaccine puzzle unearthedResearchers reveal why malaria vaccine provides just moderate safety among vaccinated childrenResearch provides prospects for new strategies to develop HIV vaccineCombination vaccines reduce the number of pictures needed while providing the same degree of protection against disease. This is an especially important advantage as childhood vaccine recommendations become increasingly complex.You can view the complete Kaiser Daily Health Plan Statement, search the archives, or join email delivery of in-depth coverage of wellness policy developments, discussions and debates. The Daily Health Plan Report is released for Kaisernetwork.org, a free of charge provider of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Panel Kaiser and Company Family members Foundation. All privileges reserved. Related StoriesStudy: Bright light therapy reduces despair and agitation in dementia sufferersHealthy adults who receive flu vaccination may also help protect old adults at higher risk for flu-related complicationsNHS hourglass structure holds back advancement of support workforce.

Almac launches six enzyme screening kits Almac’s Biocatalysis Business Continues its Strong Growth and Boosts its Presence With the Launch of the selectAZymeTM Brand While anticipated, Almac’s biocatalysis business offers expanded from its 2009 start with the sale of six enzyme screening kits, to the present supply of hundreds of kgs of chiral intermediates for drug substance manufacture, regular enzyme source to specialty chemical companies and continued growth of its screening products offering.